FDA Grants Third Emergency-Use Authorization For H7N9 Flu Test
This article was originally published in The Gray Sheet
The April 25 emergency authorization covers the use of Arbor Vita Corp.’s rapid H7N9 assay in government laboratories on U.S. citizens who are suspected of exposure to the variant of avian flu in China.
You may also be interested in...
The agency’s diagnostic office is putting to the test new authority to grant emergency use authorization for a product before an emergency is officially declared, with an upcoming coronavirus test and a recently authorized flu test.
Can Atlas Biomed unlock Japan's self-care market with its direct-to-consumer DNA and microbiome tests? HBW Insight catches up with the company's co-founder and CEO to discuss this and also how Atlas has been driving its European expansion plans despite coronavirus.
France's ANSES warns women using oral contraceptives not to use a supplement marketed by UK firm Hairburst after linking the product's consumption to two cases of severe acute hepatitis.